BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Graham EL, Koralnik IJ, Liotta EM. Therapeutic Approaches to the Neurologic Manifestations of COVID-19. Neurotherapeutics 2022. [PMID: 35861926 DOI: 10.1007/s13311-022-01267-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Rothstein TL. Cortical Grey matter volume depletion links to neurological sequelae in post COVID-19 "long haulers". BMC Neurol 2023;23:22. [PMID: 36647063 DOI: 10.1186/s12883-023-03049-1] [Reference Citation Analysis]
2 Santi Laurini G, Montanaro N, Motola D. Safety Profile of Molnupiravir in the Treatment of COVID-19: A Descriptive Study Based on FAERS Data. J Clin Med 2022;12. [PMID: 36614834 DOI: 10.3390/jcm12010034] [Reference Citation Analysis]
3 Ibrahim A, Humphries UW, Khan A, Iliyasu Bala S, Baba IA, Rihan FA. COVID-19 Model with High- and Low-Risk Susceptible Population Incorporating the Effect of Vaccines. Vaccines (Basel) 2022;11. [PMID: 36679848 DOI: 10.3390/vaccines11010003] [Reference Citation Analysis]
4 Calabrese C, Kirchner E, Calabrese LH. Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications. Best Practice & Research Clinical Rheumatology 2022. [DOI: 10.1016/j.berh.2022.101794] [Reference Citation Analysis]
5 Dang TQ, La DT, Tran TN. Myeloencephalitis as the only presentation of Omicron SARS-CoV-2 infection. BMJ Case Rep 2022;15:e251922. [DOI: 10.1136/bcr-2022-251922] [Reference Citation Analysis]
6 Xu Z, Zou Y, Gao X, Niu M, Li J, Xue L, Jiang S. Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection. Front Pharmacol 2022;13:1041331. [DOI: 10.3389/fphar.2022.1041331] [Reference Citation Analysis]
7 Visvabharathy L, Orban ZS, Koralnik IJ. Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1003103] [Reference Citation Analysis]